The Korea Exchange KOSDAQ Market Division announced on the 11th that it has given advance notice of designation as an unfaithful disclosure corporation to Jeonjin Bio Pharm due to failure to disclose and reversal of disclosure.
The deadline for the decision is the 5th of next month.
The details include 5 cases of disclosure reversal and 1 case of failure to disclose.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
